To Top

Search By Topic

Avara pharmaceutical services

16 Articles available
Acquisition

Avara Pharmaceutical Services Acquires Major Sterile Manufacturing Facility and Development Center in Canada

PR-M05-18-NI-121
Fill-Finish Services

Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services

PAP-Q2-18-CL-020
Expanded Capacity

Avara Pharmaceutical Services Hold Groundbreaking at New Aiken Site

PR-M04-18-NI-86
Acquistion

Avara Pharmaceutical Services Finalizes Acquisition of GSK Secondary Manufacturing and Packaging Facility in South Carolina

PR-M04-18-NI-015
Pharmageddon

Uniting the Industry for the Prevention of “Pharmageddon”

PAP-Q1-18-CL-001
API Manufacturing

Meeting the Need for Small-Volume API Manufacturing

PAP-Q1-18-CL-016
Leadership

Avara Pharmaceutical Services Wins CMO Leadership Awards in All 6 Categories for Contract Manufacturing

PR-M02-18-NI-016
Acquisition

Avara Acquires New OTC Solid Dose Capacity in South Carolina

PAO-M10-17-NI-001
Quality Management

Achieving a High Level of Customer Service Through Lean Quality Management

PAP-Q3-17-CL-001
Acquisition

Avara Pharmaceutical Services acquires Sterile facility from Pfizer in Italy

PR-M08-17-NI-003
Biopharmaceutical Industry

Avara on the Road to BIO: Taking Direction From Industry Veterans

Bill Pasek, Executive Vice President & Chief Commercial Officer, Avara Pharmaceutical Services
View more about Avara Pharmaceutical Services on the Road to BIO.

PTV-M06-17-CL-008
API

Optimizing API Production as a True Manufacturing Partner

PAP-Q2-17-CL-009
CDMO

A Growing CDMO

Bill Pasek, Executive Vice President & Chief Commercial Officer, Avara Pharmaceutical Services

PTV-M01-17-NS-009
API

Innovation and Partnership Through Experience and Acquisition

PAP-Q1-17-CL-013
CDMO

Delivering on Unfulfilled Promises – Building a CDMO

PAP-Q03-16-CL-006
API

Bioavailability: What Are Your Thoughts On Enhancing Bioavailability With Novel Technologies?

PAP-Q02-16-RT-001